(Tranexamic Acid 500 mg/5 ml Injection)
TEXANIS Injection contains Tranexamic Acid that acts by reversibly blocking lysine binding sites on plasminogen, thus preventing fibrin degradation and breaking down of of blood clots. Tranexamic acid may be considered as a first-line treatment for the initial management of idiopathic menorrhagia, especially for patients in whom hormonal treatment is either not recommended or not wanted.
For the reduction of peri- and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery or total knee arthroplasty or total hip arthroplasty.
Short-term control of bleeding in hemophiliacs, including dental extraction procedures.
Conditions in which bleeding control is required such as after surgery or injury, recurrent nosebleeds or abnormal vaginal bleeding and menorrhagia.